Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Capital Expenditures (2017 - 2025)

Sensus Healthcare has reported Capital Expenditures over the past 9 years, most recently at $158000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $158000.0 for Q4 2025, up 153.2% from a year ago — trailing twelve months through Dec 2025 was $196000.0 (down 28.99% YoY), and the annual figure for FY2025 was $196000.0, down 28.99%.
  • Capital Expenditures for Q4 2025 was $158000.0 at Sensus Healthcare, up from $4000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for SRTS hit a ceiling of $337000.0 in Q3 2024 and a floor of -$297000.0 in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $29000.0 (2023), compared with a mean of $52000.0.
  • Biggest five-year swings in Capital Expenditures: soared 2963.64% in 2024 and later plummeted 98.81% in 2025.
  • Sensus Healthcare's Capital Expenditures stood at $38000.0 in 2021, then plummeted by 73.68% to $10000.0 in 2022, then increased by 10.0% to $11000.0 in 2023, then plummeted by 2800.0% to -$297000.0 in 2024, then surged by 153.2% to $158000.0 in 2025.
  • The last three reported values for Capital Expenditures were $158000.0 (Q4 2025), $4000.0 (Q3 2025), and $27000.0 (Q2 2025) per Business Quant data.